Combination therapy for the treatment or prevention of tumours
US11213506B2 · kind B2 · utility
1Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2018 |
| Grant date | Jan 4, 2022 |
| Priority date | — |
| Expiry date | Mar 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2818
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combination therapy for tumours comprising the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In particular embodiments, there is a method of treating a tumour and/or treating or preventing one or more bystander tumours with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.